NovoCure Limited - Ordinary Shares (NVCR)
NVCR Stock Chart More Charts
NVCR Price/Volume Stats
| Current price | $19.05 |
| Prev. close | $18.90 |
| Day low | $18.75 |
| Day high | $19.25 |
| 50-day MA | $18.26 |
| 200-day MA | $11.38 |
| 52-week high | $21.75 |
| 52-week low | $5.95 |
| Volume | 215,173 |
| Avg. volume | 807,095 |
| Dividend yield | N/A |
| Market Cap | 1.70B |
NVCR Returns
| 1-mo | 0.79% |
| 3-mo | 45.98% |
| 6-mo | 168.31% |
| 1-year | 138.72% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | 142.68% |
| 2016 | -64.89% |
| 2015 | N/A |
| 2014 | N/A |
| 2013 | N/A |
| 2012 | N/A |
NovoCure Limited - Ordinary Shares (NVCR) Company Bio
NovoCure Limited is a commercial stage oncology company which develops treatment for solid tumor cancers therapy called the tumor treating fields. The company was founded in 2000 and is based in Saint Helier, Channel Islands.
Loading social stream, please wait...